Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study
| Autor: | Chu, V. H., Miro, J. M., Hoen, B., Cabel, C. H., Pappa, P. A., Jones, P., Stryjewski, M. E., Anguera, I., Braun, S., Muñ, oz, P., Commerford, P., Tornos, P., Francis, J., Oyonarte, M., Selton-Suty, C., Morris, A. J., Habib, G., Almirante, B., Sexton, D. J., Corey, G. R., Fowler, V. G. Jr, International Collaboration on Endocarditis-Prospective Cohort Study Group Investigators: Baršić, Bruno et al. |
|---|---|
| Přispěvatelé: | Chu, Vh, Miro, Jm, Hoen, B, Cabell, Ch, Pappas, Pa, Jones, P, Stryjewski, Me, Anguera, I, Braun, S, Muñoz, P, Commerford, P, Tornos, P, Francis, J, Oyonarte, M, Selton Suty, C, Morris, Aj, Habib, G, Almirante, B, Sexton, Dj, Corey, Gr, Fowler VG, Jr, among International Collaboration on Endocarditis Prospective Cohort Study Group, Investigator, Utili, Riccardo, Service des maladies infectieuses et tropicales, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Hôpital Saint-Jacques, Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Department of Physics [Jyväskylä Univ] (JYU), University of Jyväskylä (JYU), Service de cardiologie, Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Hôpital Saint-Jacques, Laboratoire Chrono-environnement ( LCE ), Université Bourgogne Franche-Comté ( UBFC ) -Centre National de la Recherche Scientifique ( CNRS ) -Université de Franche-Comté ( UFC ), Department of Physics, University of Jyvaskyl ( University of Jyvaskyl ), University of Jyvaskyl, Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille ( APHM ) - Hôpital de la Timone [CHU - APHM] ( TIMONE ), AII - Amsterdam institute for Infection and Immunity, Infectious diseases, Laboratoire Chrono-environnement (UMR 6249) (LCE) |
| Jazyk: | angličtina |
| Rok vydání: | 2009 |
| Předmět: |
Male
Time Factors MESH: Drug Resistance Microbial MESH : Aged MESH : Prospective Studies MESH : Coagulase 030204 cardiovascular system & hematology Postoperative Complications 0302 clinical medicine [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases MESH: Postoperative Complications MESH: Staphylococcus aureus MESH : Female Hospital Mortality Prospective Studies 030212 general & internal medicine MESH : Endocarditis Bacterial Abscess Prospective cohort study MESH: Aged Cross Infection MESH: Statistics Nonparametric MESH: Middle Aged biology MESH : Staphylococcus aureus valvular heart disease cons Drug Resistance Microbial coagulase-negative staphylococci endoccarditis prosthetic valves Middle Aged Staphylococcal Infections 3. Good health [ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseases Heart Valve Prosthesis Infective endocarditis Female MESH: Coagulase Cardiology and Cardiovascular Medicine MESH : Cross Infection Cohort study MESH : Time Factors Coagulase Staphylococcus aureus medicine.medical_specialty Prosthesis-Related Infections MESH: Heart Valve Prosthesis MESH : Male MESH: Staphylococcal Infections MESH : Bioprosthesis Statistics Nonparametric MESH : Prosthesis-Related Infections MESH : Heart Valve Prosthesis MESH : Hospital Mortality 03 medical and health sciences MESH : Drug Resistance Microbial medicine Humans Endocarditis MESH : Middle Aged MESH: Endocarditis Bacterial MESH: Hospital Mortality MESH : Statistics Nonparametric Aged Bioprosthesis MESH: Humans business.industry MESH: Prosthesis-Related Infections MESH : Humans MESH: Time Factors MESH: Cross Infection Endocarditis Bacterial medicine.disease biology.organism_classification [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology MESH: Male MESH: Prospective Studies Surgery MESH: Bioprosthesis Viridans streptococci MESH : Postoperative Complications MESH : Staphylococcal Infections business MESH: Female |
| Zdroj: | Heart Heart, BMJ Publishing Group, 2009, 95 (7), pp.570-6. ⟨10.1136/hrt.2008.152975⟩ Heart, BMJ Publishing Group, 2009, 95 (7), pp.570-6. 〈10.1136/hrt.2008.152975〉 Heart (British Cardiac Society), 95(7), 570-576. BMJ Publishing Group Heart, 2009, 95 (7), pp.570-6. ⟨10.1136/hrt.2008.152975⟩ |
| ISSN: | 1355-6037 1468-201X |
| Popis: | International audience; OBJECTIVE: To describe the contemporary features of coagulase-negative staphylococcal (CoNS) prosthetic valve endocarditis (PVE). DESIGN: Observational study of prospectively collected data from a multinational cohort of patients with infective endocarditis. Patients with CoNS PVE were compared to patients with Staphylococcus aureus and viridans streptococcal (VGS) PVE. SETTING: The International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) is a contemporary cohort of patients with infective endocarditis from 61 centres in 28 countries. PATIENTS: Adult patients in the ICE-PCS with definite PVE and no history of injecting drug use from June 2000 to August 2005 were included. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Heart failure, intracardiac abscess, death. RESULTS: CoNS caused 16% (n = 86) of 537 cases of definite non-injecting drug use-associated PVE. Nearly one-half (n = 33/69, 48%) of patients with CoNS PVE presented between 60 days and 365 days of valve implantation. The rate of intracardiac abscess was significantly higher in patients with CoNS PVE (38%) than in patients with either S aureus (23%, p = 0.03) or VGS (20%, p = 0.05) PVE. The rate of abscess was particularly high in early (50%) and intermediate (52%) CoNS PVE. In-hospital mortality was 24% for CoNS PVE, 36% for S aureus PVE (p = 0.09) and 9.1% for VGS PVE (p = 0.08). Meticillin resistance was present in 68% of CoNS strains. CONCLUSIONS: Nearly one-half of CoNS PVE cases occur between 60 days and 365 days of prosthetic valve implantation. CoNS PVE is associated with a high rate of meticillin resistance and significant valvular complications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|